Alpharma Generic Neurontin Approval Precedes FDA Reinspection
Executive Summary
Approval of Alpharma's ANDA for a generic version of Pfizer's Neurontin (gabapentin) comes just ahead of FDA's expected reinspection of the Elizabeth, N.J. facility where gabapentin will be manufactured
You may also be interested in...
Neurontin, Rebetol Generics Could Be Affected By “Shared Exclusivity” Ruling
A federal court decision invalidating FDA's "shared exclusivity" policy for first-to-file ANDAs poses another potential complication to the launch of generic versions of Pfizer's Neurontin (gabapentin)
Neurontin, Rebetol Generics Could Be Affected By “Shared Exclusivity” Ruling
A federal court decision invalidating FDA's "shared exclusivity" policy for first-to-file ANDAs poses another potential complication to the launch of generic versions of Pfizer's Neurontin (gabapentin)
Pfizer Could Launch Three Significant NMEs in 2004; Will Any Surpass Viagra?
Pfizer's product outlook is brightening in 2004, with the launch of three commercially significant new molecular entity products on the horizon
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: